Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) (HTG619)Product type:GuidanceProgramme:HealthTech guidancePublished: 30 March 2022
MMprofiler for estimating risk in newly diagnosed multiple myelomaStatus:In developmentProgramme:HealthTech guidanceExpected publication date: 6 May 2027